| Name | Polatuzumab |
|---|
| Description | Polatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b [1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |